2012
06/23

Category:
Revenue

COMMENTS:
Comments Closed

US Clinical Laboratory Testing Sector Revenue to Jump to $63.8 …

NEW YORK, NY, Jun 21, 2012 (MARKETWIRE via COMTEX) —
TriMarkPublications.com cites in its newly published “Clinical
Laboratory Testing Volume 2: Key Players for Laboratory Testing,
Business Trends and Strategies” report that U.S. clinical laboratory
testing sector revenue will jump to $63.8 billion by 2016. For more
information, visit:

http://www.trimarkpublications.com/clinical-laboratory-testing-volume-2-key-players-for-laboratory-testing-business-trends-and-strategies .

Clinical laboratory testing can be categorized into two main
modalities: clinical testing and anatomical pathology testing.
Principal tests undertaken include complete blood counts, prothrombin
and coagulation testing, thyroid stimulating hormone (TSH), lipid
panels, blood gases and electrolytes, cardiac markers, infectious
diseases, whole-blood glucose, drugs of abuse testing (DAT),
urinalysis, coagulation and cardiac monitoring. In the U.S.,
approximately 85% of clinical diagnostic testing is currently
conducted in hospital-based and commercial laboratories.

The “Clinical Laboratory Testing Volume 2: Key Players for Laboratory
Testing, Business Trends and Strategies” report covers:

— Medicare Clinical Lab Services Spending Trends
— Hospital-based Clinical Laboratories
— Commercial Clinical Laboratory Testing
— Physician Office Laboratories (POLs)
— Workplace Drugs-of-Abuse Testing
— Clinical Toxicology
— Vitamin D Testing
— Diabetes (Glucose) Testing
— Molecular Diagnostic Testing
— Cardiac Markers
— Blood Bank Screening
— Genetic Testing
— Point of Care Testing
— Anatomic Pathology
— Immunodiagnostics
— Opiate Testing

The “Clinical Laboratory Testing Volume 2: Key Players for Laboratory
Testing, Business Trends and Strategies” report examines companies
manufacturing clinical laboratory testing equipment and supplies in
the world. Companies covered include: ACM Medical, Alere, American
Esoteric (Sonic), American Pathology, AmeriPath (Quest), ARUP,
Athena, Aurora, Bio-Reference, BioTech MedLab, Caris, CBLPath,
Centrex Clinical, Clarient, Clinical Reference, Clongen, CompuNet
Clinical, EndoChoice Pathways, Enzo Biochem, Esoterix (LabCorp),
Exagen, Geneva, Genomic Health, Genzyme, IBT, Integrated Regional
(IRL), LabCorp, MEDTOX Scientific, Meriter Health Services, Mid
America Clinical (MACL), Monogram, Myriad, National Jewish Medical
and Research Center, Parkway, Pathology, Predictive, Psychemedics,
Quest, RDL Reference, Satellite Services, Signal, Solstas, Sonic and
Spectra.

Detailed charts with sales forecasts and marketshare data are
included. For more information, visit:

http://www.trimarkpublications.com/clinical-laboratory-testing-volume-2-key-players-for-laboratory-testing-business-trends-and-strategies .

About TriMarkPublications.com

TriMarkPublications.com is a global leader in the biotechnology,
healthcare and life sciences market research publishing. For more
information, please visit
http://www.trimarkpublications.com .

Important Notice

The statements contained in this news release that are
forward-looking are based on current expectations that are subject to
a number of uncertainties and risks, and actual results may differ
materially.

Contact

TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK

www.trimarkpublications.com

SOURCE: TriMarkPublications.com

http://www.trimarkpublications.com/

Copyright 2012 Marketwire, Inc., All rights reserved.

Financial Glossary

Words used in this article:





Comments are closed.